BIOMAT Database Logo BIOMAT Database Logo

The results of high risk acute lymphoblastic leukemia and non-Hodgkin's lymphoma total therapy. 1985

J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska
Results of LSA2-L2 therapy in children with high-risk acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
January 1983, Haematology and blood transfusion,
J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska
Non-Hodgkin's lymphoma complicating acute lymphoblastic leukemia in remission.
January 1988, Medical and pediatric oncology,
J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska
Reactive histiocytosis in acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
September 1986, Cancer,
J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska
Preliminary results of consolidation therapy with high-dose cytosine arabinoside for patients with bad-risk or relapsed acute leukemia or lymphoblastic non-Hodgkin's lymphoma.
April 1987, European journal of cancer & clinical oncology,
J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska
Post-therapy profile of serum total cholesterol, retinol and zinc in pediatric acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
February 2007, Journal of the American College of Nutrition,
J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska
Non hodgkin's lymphoma seven years following remission of acute lymphoblastic leukemia.
May 2004, Indian journal of pediatrics,
J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska
[Do non-localized non-Hodgkin's lymphoma and acute lymphoblastic leukemia with large tumor masses require the same therapy?].
January 1985, Haematologica,
J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska
Cranial nerve palsy in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
May 1991, Cancer,
J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska
No involvement of bovine leukemia virus in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
May 1988, Cancer research,
J Bogusławska-Jaworska, and J Pejcz, and J Armata, and M Ochocka, and U Radwańska, and R Rokicka-Milewska, and M Sroczyńska
Acute basophilic leukemia and acute eosinophilic leukemia after therapy for non-Hodgkin's lymphoma.
August 1993, American journal of clinical pathology,
Copied contents to your clipboard!